Skip to content
— CH. 1 · INTRODUCTION —

Influenza

13 min listen · Ch. 1 of 8
8 sections
  • Influenza infects between 5 and 15 percent of the global population in a typical year. The math is staggering. Somewhere between 3 and 5 million of those cases turn severe, and as many as 650,000 people die of respiratory illness from the flu each year. Most listeners know the symptoms by heart. Fever, a sore throat, a dry cough, the aching muscles that send you to bed for days. What fewer people know is that this familiar winter visitor is one of the fastest-evolving threats medicine tracks. It hides in the bodies of ducks and pigs, swaps genetic parts like a card shark trading cards, and resurfaces every decade or so as something humanity has never seen. Why does the flu come back every winter when other diseases can be defeated once and for all? Why must a new vaccine be designed every single year? And how did a virus first written about in Greek texts from the 5th century BC become the model organism that taught scientists how viruses work? The answers run from the inside of a single cell to the great pandemics that reshaped the 20th century.

  • Aquatic birds carry the original. Ducks, geese, shorebirds, and gulls are the primary reservoir of influenza A virus, the form responsible for most severe illness, seasonal epidemics, and the occasional pandemic. From this avian source the virus has spread into pigs, horses, marine mammals, and people. Influenza A is sorted into subtypes by two proteins on its surface, haemagglutinin and neuraminidase, abbreviated H and N. Almost every possible pairing of H types 1 through 16 and N types 1 through 11 has been pulled from wild birds. In humans, only two combinations circulate widely, H1N1 and H3N2.

    Influenza B virus tells a different story. It mainly infects people, though it has turned up in seals, horses, dogs, and pigs. Rather than subtypes it splits into two lineages with cumbersome names, the B/Victoria/2/1987-like and B/Yamagata/16/1988-like strains. Both have circulated in humans since 1983, and both fall hardest on children. The Yamagata lineage may have gone extinct in 2020 or 2021, possibly wiped out by the distancing measures of the COVID-19 pandemic.

    Influenza C virus rounds out the trio that affects people, usually as a mild cold in young children, and it has been detected in pigs, dogs, camels, and cattle. The fourth member, influenza D virus, was a latecomer. Discovered in 2011 in pigs in Oklahoma, it counts cattle as its natural reservoir. Cattle workers have occasionally tested positive for past infection, yet influenza D has never been shown to make a human sick. These last two evolve far more slowly than their A and B cousins, which is exactly why they spawn so few new lineages.

  • Sialic acid is the key. The viral haemagglutinin protein latches onto sialic acid receptors studding the surface of a target cell, and that single act of binding begins the infection. The cell then swallows the virus inside a bubble called an endosome. Acid floods that bubble, twisting the haemagglutinin into a new shape that fuses the viral envelope with the membrane around it. Hydrogen ions pour through the virus's M2 ion channels, the internal scaffolding loosens, and the genetic cargo spills into the cell.

    Negative-sense RNA is what spills out, a genome split into pieces. Influenza A and B carry eight segments encoding ten major proteins, while C and D carry seven. Once inside the nucleus, the viral polymerase commits a small theft. It snatches the 5-prime caps off the cell's own RNA to jump-start the manufacture of viral messages. The hijacked ribosomes of the host then crank out new viral proteins by the thousand.

    Budding is the exit. New virus particles push out through the cell membrane, wrapping themselves in a stolen patch of it loaded with haemagglutinin and neuraminidase. At the very last moment the neuraminidase acts like scissors, snipping the sialic acid that still tethers the new virus to its parent cell so it can float free and infect again. When the cell finally fills with viral RNA, it triggers its own programmed death, a last-ditch attempt to stop the copying. The virion itself takes no single shape, appearing filamentous, rod-like, or spherical, with the spherical form running about 120 nanometers across.

  • A few amino acid changes are all it takes. Antigenic drift is the slow accumulation of mutations in the genes for haemagglutinin and neuraminidase, and in the head region of haemagglutinin even a handful of swaps can let a new strain slip past antibodies the body built last year. This is the engine of seasonal flu, and the reason vaccines must be rebuilt annually. Drift runs fastest in influenza A, slower in B, and slowest of all in C and D.

    Reassortment is the sudden alternative. When two different strains infect the same cell, their segmented genomes can shuffle together and produce hybrid offspring, a process called antigenic shift. Because every influenza virus has a segmented genome, every one can reassort, though it happens most among influenza A viruses in birds. Pigs, bats, and quails are the dangerous middlemen here. Their respiratory tracts carry receptors for both bird and mammal viruses, making them mixing vessels where an animal strain can fuse with a human one. When that produces something capable of human-to-human spread, the result can be a pandemic.

    To watch for that moment, the World Health Organization runs the Global Influenza Surveillance and Response System, which tests several million specimens every year. The same machinery that updates the vaccine also stands as an early-warning network for the next shift no one can predict.

  • Two meters is the danger zone. Respiratory droplets from coughing, sneezing, talking, and even breathing are relatively large, traveling less than two meters before settling onto nearby surfaces, and most flu transmission happens in that radius around an infected person. Smaller aerosols hang in the air longer and drift further. The virus can also survive for hours on hard, non-porous surfaces, so a contaminated hand brought to the face is enough to start an infection.

    Children ages 2 to 17 are the engine of spread. They are considered the primary and most efficient spreaders, and those who have not yet built up exposure to multiple flu strains shed the virus in greater amounts and for longer than other children. A healthy adult sheds for up to three to five days, but children and people with weakened immune systems can remain infectious for weeks. The flu is usually transmissible from one day before symptoms appear to five to seven days after.

    Where the virus lands shapes how bad it gets. Strains like H1N1 that settle in the upper respiratory tract tend to be milder but more contagious, while strains like H5N1 that strike the lower respiratory tract cause more severe illness yet spread less easily. In the worst cases the lungs fill with virus and the immune system overreacts in a flood of inflammatory signals known as a cytokine storm. Severe disease often comes not from the virus alone but from pneumonia, sometimes from a secondary bacterial invader. About a third of primary pneumonia cases are followed by a secondary one, most often caused by Streptococcus pneumoniae or Staphylococcus aureus.

  • Six to eight months in a chicken egg. That is how long it takes to grow most commercial flu vaccines, which are propagated in embryonated chicken eggs. Because flu seasons differ between the northern and southern hemispheres, the World Health Organization meets twice a year, once for each, to decide which strains to include. Modern vaccines are trivalent or quadrivalent, defending against an H1N1 strain, an H3N2 strain, and one or two influenza B lineages. Most are inactivated and injected into muscle, while live attenuated versions are sprayed into the nose. They only work when the vaccine strains match what is actually circulating.

    Oseltamivir is the front-line drug. Taken orally and approved for children as young as two weeks, it is one of a class called neuraminidase inhibitors that mimic sialic acid to jam the enzyme the virus needs to escape a cell. Zanamivir is inhaled, peramivir injected, and baloxavir marboxil works by a different route entirely, attacking the endonuclease activity of the viral polymerase. These antivirals work best within the first 48 hours after symptoms begin.

    An older class has fallen out of favor. The adamantanes amantadine and rimantadine block the M2 ion channel, but resistance to them spread through H3N2 starting in 2003 and became worldwide by 2008, so they are no longer recommended. Oseltamivir resistance, by contrast, faded after the 2009 pandemic H1N1 strain, itself resistant to adamantanes, displaced the resistant strains in circulation. Today resistance is mostly seen in patients undergoing treatment, especially the immunocompromised and young children.

  • The first convincing pandemic on record struck in 1510. It began in East Asia, swept into North Africa, then Europe, and was followed by further pandemics in 1557 and 1580. The 1557 outbreak may have been the first time the flu was linked to miscarriage and the death of pregnant women. Long before that, epidemics named influenza had crossed Europe in 1173 to 1174 and again in 1387, though it stayed unclear whether the flu was truly the cause.

    The word itself carries old superstition. Influenza comes from medieval Latin influentia, meaning visitation or influence, and the 14th-century phrase influenza di stelle, influence of the stars, blamed the disease on unfavorable astrology. The shortened flu first appeared as flue in 1839, with the spelling flu confirmed in 1893.

    The deadliest chapter ran from 1918 to 1920. The Spanish flu, an H1N1 strain, likely began in the United States and spread worldwide through soldiers during and after the First World War. Its first wave was mild, but the second later in 1918 carried a far higher death rate. By the end of 1920, roughly a third to half of all people on Earth had been infected, with tens of millions dead, falling disproportionately on young adults. That catastrophe reshaped science. Richard Shope's three papers in 1931 identified a virus behind swine influenza and reignited the field. By 1933 influenza A virus was pinned as the cause of human flu, influenza B followed in 1940, and the first vaccine was licensed in the United States in 1945.

  • Seventy-five percent is the threshold. A classification system from 1981 calls an avian strain highly pathogenic if 75 percent or more of deliberately infected chickens die, while a low pathogenic strain causes mild or no symptoms. The genetic signature of the dangerous kind is a multibasic cleavage site in the haemagglutinin protein. A highly pathogenic H5N1 subtype was detected in geese in Guangdong, China in 1996, surfaced in Hong Kong poultry a year later, and has caused sporadic human cases with a high fatality rate since 1997.

    Migratory birds carry the threat across continents. In 2005 an H5N1 strain infected birds at Qinghai Lake in China, a breeding and stopover site, and from there reached more than 20 countries across Asia, Europe, and the Middle East. Ducks act as the crucial bridge, moving the virus from wild birds to free-range flocks and then into poultry, where the absence of biosecurity lets it take hold. Avian H9N2 draws special worry, because although it is low pathogenic it is a frequent donor of genes to H5N1 and H7N9 during reassortment.

    Pigs are the other great mixing vessel, carrying both the α-2,3 and α-2,6 sialic acid receptors that let bird and mammal viruses infect them alike. That dual access produced the 2009 swine flu pandemic, which originated in Mexico from a reassortment of human, swine, and avian viruses and caused hundreds of thousands of deaths. Since then H1N1, H3N2, and both influenza B lineages have circulated together as seasonal flu. Avian H7N9 began infecting people in 2013, starting in Shanghai and Anhui. With future pandemics of avian origin viewed as almost inevitable, and globalization making any new strain easier to spread, the work of preparation never stops.

Common questions

What is influenza and what causes it?

Influenza, commonly known as the flu, is an infectious disease caused by influenza viruses. There are four types, labeled A, B, C, and D, with influenza A and B responsible for the seasonal epidemics that circulate in humans.

What are the symptoms of influenza?

Influenza symptoms begin one to four days after exposure and often include sudden fever, chills, headache, muscle pain, fatigue, sore throat, and a dry cough, with coughing the most common symptom. They typically last two to eight days, and children may also experience nausea, vomiting, and diarrhea.

How many people does influenza kill each year?

In a typical year influenza infects 5 to 15 percent of the global population, causes 3 to 5 million severe cases, and is linked to as many as 650,000 respiratory-related deaths. Deaths fall most heavily on young children, the elderly, and people with chronic health conditions.

Why do influenza vaccines need to be updated every year?

Influenza viruses, especially influenza A, evolve quickly through antigenic drift, the gradual accumulation of mutations in the haemagglutinin and neuraminidase genes that lets new strains evade existing immunity. Because of this, flu vaccines are rebuilt annually to match the strains in circulation.

What were the major influenza pandemics in history?

Five flu pandemics have occurred since 1900: the Spanish flu from 1918 to 1920, which was the most severe, the Asian flu in 1957, the Hong Kong flu in 1968, the Russian flu in 1977, and the swine flu pandemic in 2009. The Spanish flu, an H1N1 strain, infected an estimated third to half of the world's population.

How is influenza treated?

Mild influenza is treated with supportive measures such as rest, fluids, and anti-fever medication, while severe cases may require antiviral drugs like oseltamivir. Antivirals work best when started within the first 48 hours after symptoms appear.

How does influenza spread between people?

Influenza spreads mainly through respiratory droplets from coughing and sneezing, which travel less than two meters, as well as through smaller aerosols and contaminated surfaces. Children ages 2 to 17 are considered the primary and most efficient spreaders of the virus.

All sources

96 references cited across the entry

  1. 1Influenza (seasonal)28 February 2025
  2. 3Flu Symptoms & ComplicationsU.S. Centers for Disease Control and Prevention (CDC) — 26 February 2019
  3. 4JournalDoes this patient have influenza?Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP — February 2005
  4. 5JournalPrevention and treatment of the common cold: making sense of the evidenceAllan GM, Arroll B — February 2014
  5. 6Cold Versus Flu11 August 2016
  6. 7JournalInfluenzaDharmapalan D — October 2020
  7. 8JournalInfluenzaKrammer F, Smith GJ, Fouchier RA, Peiris M, Kedzierska K, Doherty PC, Palese P, Shaw ML, Treanor J, Webster RG, García-Sastre A — June 2018
  8. 9JournalInfluenzaGhebrehewet S, MacPherson P, Ho A — December 2016
  9. 10JournalEpidemiology and Clinical Characteristics of Influenza C VirusSederdahl BK, Williams JV — January 2020
  10. 11JournalHuman Influenza Virus InfectionsPeteranderl C, Herold S, Schmoldt C — August 2016
  11. 12People also suffer 'long flu', study showsTriggle N — 28 September 2021
  12. 13Press release'Long flu' has emerged as a consequence similar to long COVIDSauerwein K — 14 December 2023
  13. 14JournalLong-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort studyXie Y, Choi T, Al-Aly Z — March 2024
  14. 15JournalInfluenza virus-related critical illness: pathophysiology and epidemiologyKalil AC, Thomas PG — July 2019
  15. 16Virus Taxonomy: 2019 ReleaseInternational Committee on Taxonomy of Viruses
  16. 17JournalAvian influenza viruses in humans: lessons from past outbreaksLi YT, Linster M, Mendenhall IH, Su YC, Smith GJ — December 2019
  17. 18JournalThe ecology and adaptive evolution of influenza A interspecies transmissionJoseph U, Su YC, Vijaykrishna D, Smith GJ — January 2017
  18. 19Influenza Type A VirusesCDC — 1 February 2024
  19. 21JournalEmerging Influenza D Virus Threat: What We Know so Far!Asha K, Kumar B — February 2019
  20. 23JournalTowards a universal influenza vaccine: different approaches for one goalSautto GA, Kirchenbaum GA, Ross TM — January 2018
  21. 24JournalInfluenza lineage extinction during the COVID-19 pandemic?Koutsakos M, Wheatley AK, Laurie K, Kent SJ, Rockman S — December 2021
  22. 25JournalNovel Influenza D virus: Epidemiology, pathology, evolution and biological characteristicsSu S, Fu X, Li G, Kerlin F, Veit M — November 2017
  23. 27JournalA revision of the system of nomenclature for influenza viruses: a WHO Memorandum1980
  24. 29OrthomyxoviridaeMcCauley JW, Hongo S, Kaverin NV, Kochs G, Lamb RA, Matrosovich MN, Perez DR, Palese P, Presti PM, Rimstad E, Smith GJ — International Committee on Taxonomy of Viruses — 2011
  25. 30JournalInfluenza Virus Infection, Interferon Response, Viral Counter-Response, and ApoptosisShim JM, Kim J, Tenson T, Min JY, Kainov DE — August 2017
  26. 31JournalRoles of the Non-Structural Proteins of Influenza A VirusHao W, Wang L, Li S — October 2020
  27. 32JournalFilamentous influenza virusesDadonaite B, Vijayakrishnan S, Fodor E, Bhella D, Hutchinson EC — August 2016
  28. 33JournalH3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluationAllen JD, Ross TM — 2018
  29. 34JournalReviewing the History of Pandemic Influenza: Understanding Patterns of Emergence and TransmissionSaunders-Hastings PR, Krewski D — December 2016
  30. 35JournalA brief history of bird fluLycett SJ, Duchatel F, Digard P — June 2019
  31. 36JournalLeveraging the Global Influenza Surveillance and Response System for global respiratory syncytial virus surveillance-opportunities and challengesBroor S, Campbell H, Hirve S, Hague S, Jackson S, Moen A, Nair H, Palekar R, Rajatonirina S, Smith PG, Venter M, Wairagkar N, Zambon M, Ziegler T, Zhang W — November 2020
  32. 37JournalTransmission routes of respiratory viruses among humansKutter JS, Spronken MI, Fraaij PL, Fouchier RA, Herfst S — February 2018
  33. 38JournalInfluenza and antiviral resistance: an overviewLampejo T — July 2020
  34. 39JournalRoutes of influenza transmissionKillingley B, Nguyen-Van-Tam J — September 2013
  35. 40JournalInactivation of influenza A viruses in the environment and modes of transmission: a critical reviewWeber TP, Stilianakis NI — November 2008
  36. 41JournalSeasonality of Respiratory Viral InfectionsMoriyama M, Hugentobler WJ, Iwasaki A — September 2020
  37. 42JournalConformation and Linkage Studies of Specific Oligosaccharides Related to H1N1, H5N1, and Human Flu for Developing the Second TamifluYoo E — February 2014
  38. 43JournalEvolution of Influenza A Virus by Mutation and Re-AssortmentShao W, Li X, Goraya MU, Wang S, Chen JL — August 2017
  39. 44JournalRole of hemagglutinin cleavage for the pathogenicity of influenza virusSteinhauer DA — May 1999
  40. 45JournalSnapShot: Influenza by the NumbersEinav T, Gentles LE, Bloom JD — July 2020
  41. 46JournalInfluenza virus-related critical illness: prevention, diagnosis, treatmentChow EJ, Doyle JD, Uyeki TM — June 2019
  42. 47JournalAdjuvanted influenza vaccinesTregoning JS, Russell RF, Kinnear E — March 2018
  43. 48JournalProtection of children against influenza: Emerging problemsPrincipi N, Esposito S — March 2018
  44. 49JournalCell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectivenessBarr IG, Donis RO, Katz JM, McCauley JW, Odagiri T, Trusheim H, Tsai TF, Wentworth DE — October 2018
  45. 502009 H1N1 Flu ("Swine Flu") and YouCenters for Disease Control and Prevention (CDC) — 10 February 2010
  46. 51JournalEfficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteersGrayson ML, Melvani S, Druce J, Barr IG, Ballard SA, Johnson PD, Mastorakos T, Birch C — February 2009
  47. 52JournalNon-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence baseAledort JE, Lurie N, Wasserman J, Bozzette SA — August 2007
  48. 53JournalFace mask use and control of respiratory virus transmission in householdsMacIntyre CR, Cauchemez S, Dwyer DE, Seale H, Cheung P, Browne G, Fasher M, Wood J, Gao Z, Booy R, Ferguson N — February 2009
  49. 54JournalTransmission of influenza: implications for control in health care settingsBridges CB, Kuehnert MJ, Hall CB — October 2003
  50. 55Interim Guidance for the Use of Masks to Control Seasonal Influenza Virus TransmissionCenters for Disease Control and Prevention (CDC) — 5 March 2019
  51. 56JournalRespiratory tract infections: another reason not to smokeMurin S, Bilello KS — October 2005
  52. 57JournalCigarette smoking as a risk factor for epidemic a(h1n1) influenza in young menKark JD, Lebiush M, Rannon L — October 1982
  53. 58JournalContamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection?Hota B — October 2004
  54. 59JournalAntiseptics and disinfectants: activity, action, and resistanceMcDonnell G, Russell AD — January 1999
  55. 60Chlorine Bleach: Helping to Manage the Flu RiskWater Quality & Health Council — April 2009
  56. 61Avian Influenza (AI)U.S. Department of Agriculture, Animal and Plant Health Inspection Service
  57. 62JournalCurrent Approaches for Diagnosis of Influenza Virus Infections in HumansVemula SV, Zhao J, Liu J, Wang X, Biswas S, Hewlett I — April 2016
  58. 63Flu: MedlinePlus Medical EncyclopediaU.S. National Library of Medicine
  59. 64JournalKawasaki disease and influenza-new lessons from old associationsBanday AZ, Arul A, Vignesh P, Singh MP, Goyal K, Singh S — July 2021
  60. 65JournalCorticosteroids as adjunctive therapy in the treatment of influenzaLouise Lansbury et al. — 2019-02-24
  61. 66LaninamivirNational Center for Advancing Translational Sciences
  62. 70JournalA history of influenzaPotter CW — October 2001
  63. 71JournalInfluenza: old and new threatsPalese P — December 2004
  64. 72BookInternet-Based Intelligence in Public Health Emergencies: Early Detection and Response in Disease Outbreak CrisesIOS Press — 2013
  65. 73Journal2,500-year evolution of the term epidemicMartin PM, Martin-Granel E — June 2006
  66. 74JournalEyewitness accounts of the 1510 influenza pandemic in EuropeMorens DM, North M, Taubenberger JK — December 2010
  67. 75JournalThe earliest American epidemic. The influenza of 1493Guerra F — 1988
  68. 76JournalThe European-American exchangeGuerra F — 1993
  69. 77JournalPandemic influenza's 500th anniversaryMorens DM, Taubenberger JK, Folkers GK, Fauci AS — December 2010
  70. 78BookThe Threat of Pandemic Influenza: Are We Ready? Workshop Summary (2005)Institute of Medicine (US) Forum on Microbial Threats — The National Academies Press — 2005
  71. 79JournalDiscovery and characterization of the 1918 pandemic influenza virus in historical contextTaubenberger JK, Hultin JV, Morens DM — 2007
  72. 80JournalComplete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission eventVijgen L, Keyaerts E, Moës E, Thoelen I, Wollants E, Lemey P, Vandamme AM, Van Ranst M — February 2005
  73. 81Journal1918 Influenza: the mother of all pandemicsTaubenberger JK, Morens DM — January 2006
  74. 82JournalA virus obtained from influenza patientsSmith W, Andrewes CH, Laidlaw PP — 1933
  75. 83JournalEffectiveness of personal protective measures in reducing pandemic influenza transmission: A systematic review and meta-analysisSaunders-Hastings P, Crispo JA, Sikora L, Krewski D — September 2017
  76. 84JournalSwine influenza: a zoonosisHeinen PP — 15 September 2003
  77. 85JournalThe Spanish flu and the fiction literatureVázquez-Espinosa E, Laganà C, Vázquez F — October 2020
  78. 86influenza (n.)Online Etymology Dictionary
  79. 87influenzaOxford English Dictionary
  80. 88flu (n.)Online Etymology Dictionary
  81. 89JournalSwine fluCalisher CH — August 2009
  82. 90JournalHistory of highly pathogenic avian influenzaAlexander DJ, Brown IH — April 2009
  83. 91Factsheet on A(H5N1)15 June 2017
  84. 93Swine influenzaWorld Organisation for Animal Health
  85. 96JournalHuge amounts of bird-flu virus found in raw milk of infected cowsKozlov M — June 2024